Altasciences is an integrated, full-service CRO/CDMO headquartered in Montréal, Canada, with nine total facilities across North America. Founded in 1992, Altasciences provides proactive drug development services for both small and large molecule drug products to clients, scaling up from preclinical through clinical and commercial services. Their services include early-phase drug development, formulation development, phase I through commercial manufacturing, and ICH stability testing.
